CTLA4 and melanoma: Melanomas from patients who developed brain metastases contained significantly higher levels of (CD45+) immune cells and overexpressed fibronectin and CTLA-4 in all ROIs compared to the melanomas that had metastasized to other sites than the brain (p<0.05).